These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 24964524)

  • 21. Testosterone, cardiovascular disease and the metabolic syndrome.
    Corona G; Rastrelli G; Vignozzi L; Mannucci E; Maggi M
    Best Pract Res Clin Endocrinol Metab; 2011 Apr; 25(2):337-53. PubMed ID: 21397202
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optimal diagnostic measures and thresholds for hypogonadism in men with HIV/AIDS: comparison between 2 transdermal testosterone replacement therapy gels.
    Blick G
    Postgrad Med; 2013 Mar; 125(2):30-9. PubMed ID: 23816769
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of testosterone on cardiovascular disease: a critical review of the literature.
    Su JJ; Park SK; Hsieh TM
    Am J Mens Health; 2014 Nov; 8(6):470-91. PubMed ID: 24563500
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Testosterone in old age: an up-date].
    Hilbert-Walter A; Büttner R; Sieber C; Bollheimer C
    Dtsch Med Wochenschr; 2012 Oct; 137(41):2117-22. PubMed ID: 23033170
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnosis and treatment of hypogonadism in men.
    Bhasin S; Basaria S
    Best Pract Res Clin Endocrinol Metab; 2011 Apr; 25(2):251-70. PubMed ID: 21397197
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Testosterone deficiency.
    Traish AM; Miner MM; Morgentaler A; Zitzmann M
    Am J Med; 2011 Jul; 124(7):578-87. PubMed ID: 21683825
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiovascular effect of testosterone replacement therapy in aging male.
    Francomano D; Bruzziches R; Natali M; Aversa A; Spera G
    Acta Biomed; 2010; 81 Suppl 1():101-6. PubMed ID: 20518199
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Testosterone deficiency: which patients should you screen and treat?
    Sadovsky R; Dhindsa S; Margo K
    J Fam Pract; 2007 May; 56(5 Suppl Testosterone):S1-20; quiz S21-3. PubMed ID: 17475159
    [No Abstract]   [Full Text] [Related]  

  • 29. Androgen deficiency in the aging male: a guide to diagnosis and testosterone replacement therapy.
    Raynor MC; Carson CC; Pearson MD; Nix JW
    Can J Urol; 2007 Dec; 14 Suppl 1():63-8. PubMed ID: 18163948
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Testosterone replacement therapy: For whom, when and how?
    Tsametis CP; Isidori AM
    Metabolism; 2018 Sep; 86():69-78. PubMed ID: 29530796
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Current understanding of the role of age-related hypogonadism in the development of cardiovascular diseases].
    Lebedeva NB; Hoffman VV
    Ter Arkh; 2021 Jan; 93(1):79-83. PubMed ID: 33720630
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Counterpoint: urologists should take an active role in the diagnosis and treatment of hypogonadism in the aging male.
    Casey RW
    Can J Urol; 2002 Dec; 9(6):1681-3. PubMed ID: 12517309
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risks of testosterone-replacement therapy and recommendations for monitoring.
    Rhoden EL; Morgentaler A
    N Engl J Med; 2004 Jan; 350(5):482-92. PubMed ID: 14749457
    [No Abstract]   [Full Text] [Related]  

  • 34. [Correction of androgen deficiency in elderly patients].
    Morgunov LIu
    Klin Med (Mosk); 2007; 85(9):17-22. PubMed ID: 18038561
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Testosterone and cardiovascular risk.
    Tirabassi G; Gioia A; Giovannini L; Boscaro M; Corona G; Carpi A; Maggi M; Balercia G
    Intern Emerg Med; 2013 Apr; 8 Suppl 1():S65-9. PubMed ID: 23475207
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Testosterone deficiency as a risk factor for cardiovascular disease.
    Ullah MI; Washington T; Kazi M; Tamanna S; Koch CA
    Horm Metab Res; 2011 Mar; 43(3):153-64. PubMed ID: 21283952
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Testosterone administration in older men.
    Matsumoto AM
    Endocrinol Metab Clin North Am; 2013 Jun; 42(2):271-86. PubMed ID: 23702401
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Testosterone replacement therapy for late-onset hypogonadism.
    Cunningham GR
    Nat Clin Pract Urol; 2006 May; 3(5):260-7. PubMed ID: 16691239
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of testosterone replacement on whole body glucose utilisation and other cardiovascular risk factors in males with idiopathic hypogonadotrophic hypogonadism.
    Tripathy D; Shah P; Lakshmy R; Reddy KS
    Horm Metab Res; 1998 Oct; 30(10):642-5. PubMed ID: 9851674
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ISA, ISSAM and EAU recommendations for the investigation, treatment and monitoring of late-onset hypogonadism in males: scientific background and rationale.
    Lunenfeld B; Saad F; Hoesl CE
    Aging Male; 2005 Jun; 8(2):59-74. PubMed ID: 16096160
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.